A REVIEW OF OXYCODONES CLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS

被引：97

作者：

POYHIA, R

VAINIO, A

KALSO, E

机构：

[1] Department of Anesthesia, University of Helsinki, Helsinki

[2] Department of Anesthesia, Terhokoti Hospice, Helsinki

来源：

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 1993年 / 8卷 / 02期

关键词：

OXYCODONE; MORPHINE; CANCER PAIN; ACUTE POSTOPERATIVE PAIN; POSTTRAUMATIC PAIN; PHARMACOLOGY;

D O I：

10.1016/0885-3924(93)90101-Z

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Oxycodone (14-hydroxy-7,8-dihydrocodeinone) is a strong apioid agonist that is available alone or in combination with mild analgesics. It is suitable for oral administration due to high bioavailability (60 %), and may also be given intramuscularly, intravenously, subcutaneously, and rectally; it is not recommended for spinal administration. In analgesic potency, oxycodone is comparable to morphine. With the exception of hallucinations, which may occur more rarely after oxycodone than after morphine, the side effects of these drugs are closely related. The abuse potential of oxycodone is equivalent to that of morphine. The usual indications for oxycodone are severe acute postoperative or posttraumatic pain and cancer pain. When oxycodone is administered, the same precautions should be taken as with morphine or other agonist opioids.

引用

页码：63 / 67

页数：5

共 31 条

[1] Maruta, Swanson, Problems with the use of oxycodone compound in patients with chronic pain, Pain, 11, pp. 389-396, (1981)
[2] Tien, Transdermal-controlled administration of oxycodone, J Pharm Sci, 80, pp. 741-743, (1991)
[3] Index nominum: international drug directory 1990–1991, (1990)
[4] Foley, Inturrisi, Pharmacologic approaches to cancer pain, Current therapy of pain, pp. 303-331, (1988)
[5] Hoskin, Hanks, Opioid therapy in malignant disease, Update in opioids, Ballière's clinical anesthesiology, international practice and research, 1, pp. 883-904, (1987)
[6] Mather, Analgesic drugs, Anesthesia, pp. 73-104, (1989)
[7] Twycross, Opioid analgesics in cancer pain: current practice and controversies, Cancer Surv, 7, pp. 29-53, (1988)
[8] Beaver, Wallenstein, Rogers, Houde, Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone, J Pharmacol Exp Ther, 207, pp. 92-100, (1978)
[9] Beaver, Wallenstein, Houde, Rogers, Analgesic studies of codeine and oxycodone in patients with cancer II. Comparisons of intramuscular oxycodone with intramuscular morphine and codeine, J Pharmacol Exp Ther, 207, pp. 101-108, (1978)
[10] Kalso, Vainio, Morphine and oxycodone hydrochloride in the management of cancer pain, Clin Pharmacol Ther, 47, pp. 639-646, (1990)

← 1 2 3 4 →